drugset / Trial / NCT02526576

Adipose Derived Stem Cells in Facial Fat Grafting

NCT02526576

Phase 2 Completed 34 enrolled Antria
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one year.

Timeline

Start
2015-08
Primary completion
2017-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy

Indications